<DOC>
	<DOCNO>NCT00681109</DOCNO>
	<brief_summary>The purpose study determine effectiveness safety Topical Interleukin-1-Receptor Antagonist treatment sign symptom posterior blepharitis .</brief_summary>
	<brief_title>Topical IL-1-Ra Treatment Posterior Blepharitis</brief_title>
	<detailed_description />
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>A diagnosis posterior blepharitis A negative urine pregnancy test result woman childbearing potential Women childbearing potential must agree use adequate contraception ( hormonal barrier method birth control ) prior study entry duration study participation Normal lid position closure Ability understand provide inform consent participate study Willingness follow study instruction likely complete require visit . History StevensJohnson syndrome ocular pemphigoid History eyelid surgery Intraocular surgery ocular laser surgery within 3 month History microbial keratitis , include herpes Active ocular allergy Corneal epithelial defect &gt; 1mm2 Use topical steroid Restasis within past 2 week Use tetracycline compound ( tetracycline , doxycycline , minocycline ) within last month Use isotretinoin ( Accutane ) within past 6 month Have previous treatment Anakinra ( KineretÂ® ) therapeutic agent target IL1 blockade Pregnant lactate woman Signs current infection , include fever current treatment antibiotic Liver , renal , hematologic disease The use investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>